# Contingent Value Rights (CVR)

## 中文解释 / English Explanation

* **定义 / Definition**  
  - **中文解释**  
    或有价值权利（Contingent Value Rights, CVR）是一种金融工具，通常在企业并购或重组过程中发行。CVR赋予持有者在未来某一特定事件发生时（如达到某个财务目标、获得监管批准或实现特定里程碑）获得额外支付或补偿的权利。CVR的价值取决于未来事件的不确定性，因此具有较高的风险性。  
  - **English Explanation**  
    Contingent Value Rights (CVR) are financial instruments typically issued during mergers, acquisitions, or corporate restructurings. CVRs grant holders the right to receive additional payments or compensation if a specific future event occurs (e.g., achieving a financial target, obtaining regulatory approval, or reaching a milestone). The value of CVRs depends on the uncertainty of future events, making them inherently risky.

* **应用 / Application**  
  - **中文应用场景**  
    CVR常用于并购交易中，作为对卖方的一种激励或补偿机制。例如，买方可能通过发行CVR来降低交易价格，同时承诺在未来达到某些条件时支付额外款项。CVR也用于生物科技或制药行业，当新药获得批准或达到销售目标时，投资者可获得额外回报。需要注意的是，CVR的价值高度依赖于未来事件的不确定性，投资者需谨慎评估风险。  
  - **English Application**  
    CVRs are commonly used in M&A transactions as an incentive or compensation mechanism for sellers. For example, a buyer might issue CVRs to reduce the upfront purchase price while promising additional payments if certain conditions are met in the future. CVRs are also used in the biotech or pharmaceutical industries, where investors receive additional payouts if a new drug is approved or sales targets are achieved. It is important to note that the value of CVRs is highly dependent on the uncertainty of future events, requiring investors to carefully assess risks.

* **重要性 / Significance**  
  - **中文重要性**  
    从监管角度看，CVR为并购交易提供了灵活性，有助于平衡买卖双方的利益。从投资角度看，CVR为投资者提供了参与未来潜在收益的机会，但也伴随着较高的风险。从行业角度看，CVR在生物科技、制药等高研发投入行业中尤为重要，因为这些行业的成功往往依赖于未来的不确定性事件。  
  - **English Significance**  
    From a regulatory perspective, CVRs provide flexibility in M&A transactions, helping to balance the interests of buyers and sellers. From an investment perspective, CVRs offer investors the opportunity to participate in potential future gains, albeit with higher risks. From an industry perspective, CVRs are particularly important in sectors like biotech and pharmaceuticals, where success often hinges on uncertain future events.

## 历史典故 / Historical Context

* **起源 / Origin**  
  - **中文起源**  
    CVR的概念最早可追溯到20世纪80年代的美国并购浪潮。当时，许多公司通过发行CVR来降低交易成本并分担风险。例如，1989年，制药公司Bristol-Myers Squibb在收购抗癌药物公司Oncology Therapeutics Network时，首次大规模使用了CVR。此后，CVR逐渐成为并购交易中的常见工具，尤其是在涉及高不确定性行业的交易中。  
  - **English Origin**  
    The concept of CVRs dates back to the M&A boom in the United States during the 1980s. At that time, many companies used CVRs to reduce transaction costs and share risks. For example, in 1989, pharmaceutical company Bristol-Myers Squibb pioneered the large-scale use of CVRs in its acquisition of Oncology Therapeutics Network. Since then, CVRs have become a common tool in M&A transactions, especially in industries with high uncertainty.

* **影响 / Impact**  
  - **中文影响**  
    CVR的引入对并购市场产生了深远影响。它使得买卖双方能够在交易中更好地分配风险，特别是在涉及高不确定性资产的交易中。如今，CVR在生物科技、制药、能源等行业的并购中广泛应用。然而，由于其价值高度依赖于未来事件，CVR的市场表现也常常波动较大。  
  - **English Impact**  
    The introduction of CVRs has had a profound impact on the M&A market. It allows buyers and sellers to better allocate risks in transactions, particularly those involving highly uncertain assets. Today, CVRs are widely used in M&A deals in industries such as biotech, pharmaceuticals, and energy. However, due to their dependence on future events, the market performance of CVRs is often highly volatile.

## 要点总结 / Takeaway

* **中文**  
  - **核心价值**：CVR是一种基于未来事件的金融工具，为投资者提供了参与潜在收益的机会。  
  - **使用场景**：常用于并购交易、生物科技和制药行业，用于分担风险和激励目标达成。  
  - **延伸意义**：CVR体现了金融工具在不确定性环境中的创新应用，但也要求投资者具备较高的风险承受能力。  

* **English**  
  - **Key Point 1**: CVRs are financial instruments tied to future events, offering investors the chance to participate in potential gains.  
  - **Key Point 2**: Commonly used in M&A transactions and industries like biotech and pharmaceuticals to share risks and incentivize target achievements.  
  - **Key Point 3**: CVRs represent an innovative application of financial tools in uncertain environments but require investors to have a high risk tolerance.